Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|Trovagene Commences Non-Deal Investor Ro...||07/15/19|
|SAN DIEGO, July 15, 2019 /PRNewswire/ -- Trovagene, Inc. (Nasdaq: TROV), a clinical-stage, Precision Cancer Medicine™ company, developing targeted the...|
|Trovagene Announces Initiation of Enroll...||07/09/19|
|SAN DIEGO, July 9, 2019 /PRNewswire/ -- Trovagene, Inc. (Nasdaq: TROV), a clinical-stage, Precision Cancer Medicine™ oncology therapeutics company, to...|
|Date||2019-05-07 (AMC)||Est. (EPS/Rev.)||($1.07)/ 170K|
|Actual (EPS/Rev.)||$-1.02/ $162.00 K||EPS (TTM)||0|